Vivo Opportunity Fund Holdings, L.P. - 01 Dec 2025 SCHEDULE 13G Report for Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA)

Filing Manager
Vivo Opportunity Fund Holdings, L.P.
Reporting Manager
Vivo Opportunity Fund Holdings, L.P.
Security
Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share
Symbol
KTTA
Shares outstanding
175,780,450 shares
Disclosed Ownership
17,560,467 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
05 Dec 2025, 16:00:24 UTC
Date of event
01 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Vivo Opportunity Fund Holdings, L.P. disclosed 10% ownership in Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA) on 01 Dec 2025."

Quick Takeaways

  • Vivo Opportunity Fund Holdings, L.P. filed SCHEDULE 13G for Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA).
  • Disclosed ownership: 10%.
  • Date of event: 01 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 05 Dec 2025, 16:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vivo Opportunity Fund Holdings, L.P. 10% 17,560,467 17,560,467 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Vivo Opportunity, LLC 10% 17,560,467 17,560,467 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity Cayman Fund, L.P. 10% 1,772,867 1,772,867 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity Cayman, LLC, General Partner
Vivo Opportunity Cayman, LLC 10% 1,772,867 1,772,867 0 /s/ Kevin Dai Kevin Dai/Managing Member

Sponsored